ABCSG Events

Here you can find the announcements of upcoming English-language ABCSG events and trainings.

Antibody-Drug-Conjugates: State-of-the-Art Cancer Treatments

E-LEARNING: Antibody-Drug-Conjugates: State-of-the-Art Cancer Treatments

Date: Available in the members area
Start/End: 1,5 hours
Location: virtual

The ABCSG E-Learning on ADCs in Breast Cancer Treatment is a joint project of ABCSG and Daiichi Sankyo.

Information
CDK4/6 inhibition in early breast cancer

SAVE THE DATE:
CDK4/6 inhibition in early breast cancer – Recent data and controversies?

Date: 08.11.2023
Start/End: 05.30 – 07.00 pm (CET)
Location: virtual

  • Study monarchE
  • Study NATALEE
Information & Registration

Past ABCSG Events

Here you can find past ABCSG English-language E-Learnings and Webinars.

Paradigm shift: a changing CDK4/6 inhibitor treatment landscape

Paradigm shift: a changing CDK4/6 inhibitor treatment landscape – NOW ONLINE!

Date: 14.09.2023
Start/End: 6.00 – 8.00 pm (CET)
Location: virtual

Cyclin-dependent kinase (CDK) 4/6 inhibitors have proven to be game changer as targeted cancer therapy of patients with hormone receptor-positive breast cancer and they have established as standard of care for the treatment of advanced HR+ breast cancer. Also, mechanisms of resistance to CDK4/6 inhibitors, biomarker analyses to better select patients who derive the greatest benefit from CDK4/6 inhibitors, in both early and advanced settings, and more issues have been elucidated.

read more
The Changing Treatment Landscape of CDK4/6 Inhibitors

The Changing Treatment Landscape of CDK4/6 Inhibitors
Moving From Late to Early Stages – 09 May 2022

Date: May 09, 2022
Start/End: 6.00-8.00 pm (CET)
Location: virtual

Cyclin-dependent kinase (CDK) 4/6 inhibitors have emerged as an appealing targeted cancer therapy of patients with hormone receptor-positive breast cancer. Prior to the availability of CDK4/6 inhibitors, standard first-line therapy for patients with HR+/HER2- mBC was single-agent endocrine therapy.

read more
New E-Learning on "ADCs in Breast Cancer Treatment"

New E-Learning on “ADCs in Breast Cancer Treatment”

Date: July 2021
Location: virtual

This new e-learning on „ADCs in BC Treatment” is a joint project with Daiichi Sankyo and AstraZeneca

read more

ABCSG Events Archive

Share on


Top